A SARS-CoV-2 ferritin nanoparticle vaccine elicits broad immunity
| Date | 13th, May 2021 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.